Clinical Evaluation of Recombinant Human Bone Morphogenetic Protein-2
A. Valentin-Opran(Inserm), Gerard E. Riedel(Andover Eye Associates), Cristina Csimma(Women's Health Research Institute), Leslie C. Lilly, John M. Wozney
Cited by 290
Related Papers
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES
|Journal of Bone and Joint Surgery|2002|1.3k
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
|Biochemical and Biophysical Research Communications|1990|497
Transforming Growth Factor-β Gene Family Members and Bone*
|Endocrine Reviews|1994|489
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
|Annals of Neurology|2008|466
Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects
|Journal of Bone and Joint Surgery|2006|447